Skip to main content
Veterinary Medicines

Innovax-ND-ILT (--) - Concentrate and solvent for suspension for injection

Authorised
  • Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live

Product identification

Medicine name:
Innovax-ND-ILT (--) - Concentrate and solvent for suspension for injection
Active substance:
  • Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live
Target species:
  • Chicken
  • Chicken (embryonated eggs)
Route of administration:
  • In ovo
  • Subcutaneous use

Product details

Active substance and strength:
  • Turkey herpesvirus, strain HVT/NDV/ILT (cell-associated), expressing fusion protein gene of Newcastle disease virus and gD and gI glycoproteins genes of Infectious laryngotracheitis virus, Live
    Presentation_strength:10³·³ – 10⁴·³ PFU Comments:per dose in concentrate Index:0
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • In ovo
    • Chicken
      • Not applicable
        0
        day
  • Subcutaneous use
    • Chicken
      • Not applicable
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Available in:
  • Austria
  • Belgium
  • Bulgaria
  • Czechia
  • Denmark
  • France
  • Germany
  • Hungary
  • Italy
  • Netherlands
  • Poland
  • Romania
  • Spain
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Concentrate: ampoule (glass), Package_size:Concentrate: 1 ampoule, Content:Concentrate: 4000 doses
  • Packaging:Concentrate: ampoule (glass), Package_size:Concentrate: 1 ampoule, Content:Concentrate: 2000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 5/02/2024
Download
Bulgarian (PDF)
Published on: 5/02/2024
Croatian (PDF)
Published on: 5/02/2024
Czech (PDF)
Published on: 5/02/2024
Danish (PDF)
Published on: 5/02/2024
Dutch (PDF)
Published on: 5/02/2024
Estonian (PDF)
Published on: 5/02/2024
Finnish (PDF)
Published on: 5/02/2024
French (PDF)
Published on: 5/02/2024
German (PDF)
Published on: 5/02/2024
Greek (PDF)
Published on: 5/02/2024
Hungarian (PDF)
Published on: 5/02/2024
Icelandic (PDF)
Published on: 5/02/2024
Italian (PDF)
Published on: 5/02/2024
Latvian (PDF)
Published on: 5/02/2024
Lithuanian (PDF)
Published on: 5/02/2024
Maltese (PDF)
Published on: 5/02/2024
Norwegian (PDF)
Published on: 5/02/2024
Polish (PDF)
Published on: 5/02/2024
Portuguese (PDF)
Published on: 5/02/2024
Romanian (PDF)
Published on: 5/02/2024
Slovak (PDF)
Published on: 5/02/2024
Slovenian (PDF)
Published on: 5/02/2024
Spanish (PDF)
Published on: 5/02/2024
Swedish (PDF)
Published on: 5/02/2024

ema-puar-innovax-nd-ilt-v-5190-par-en.pdf

English (PDF)
Published on: 14/03/2023
Download